Jung-Min Lee

Last updated
Jung-Min Lee
Jung-Min Lee.jpg
Alma mater Yonsei University (MD)
Scientific career
Fields Medical oncology, clinical trials, drug development
Institutions National Cancer Institute

Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple-negative breast cancer. She is a NIH Lasker Clinical Research Scholar and principal investigator in the Women's Malignancies Branch at the National Cancer Institute.

Contents

Early life and education

Lee is a earned a MD at Yonsei University Wonju College of Medicine. She completed a residency in internal medicine at Holy Family Hospital, Catholic University of Korea. At the age of 26, she immigrated to the United States. Lee conducted a research fellowship in pathology and cell biology at Thomas Jefferson University and residency training in internal medicine at the Albert Einstein College of Medicine. [1] She completed a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan Kettering Cancer Center. [2] [3] From 2008 to 2012, Lee was a medical oncology and hematology fellow at the National Cancer Institute's (NCI) Medical Oncology Branch (MOB). [1]

Career and research

Lee has been a NIH Lasker Clinical Research Scholar since 2016. Lee studies BRCA mutation-mediated cancers such as ovarian and breast cancer. [1] In 2012, Lee became an assistant clinical investigator at NCI and joined the Molecular Signaling Section/Women's Cancers Clinic, MOB, to investigate potential biomarkers and develop rational combinations of targeted therapies for rare subsets of women's cancers.[1][2] Lee is a participating member in the Gynecologic Oncology Group, American Association for Cancer Research, American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies Faculty of the NCI Center for Cancer Research (CCR).[2]

Lee’s research is focused on clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple negative breast cancer, as these diseases share similar molecular abnormalities. Her clinical and translational research interests include examining the hypothesis of clinical synergy of the combination of targeting key proteins in the DNA damage repair pathways, cell cycle, tumor microenvironment, and immune check points in clinical trials, incorporating collected patient tissue and blood samples. She is the principal investigator of ongoing phase 1 and 2 studies, with a PARP inhibitor (olaparib) in combination with carboplatin or cediranib, and other biologic agents.[2][3] Lee’s clinical trial is the first to test the modulation of immune-checkpoint activity by increasing the antigenic microenvironment with active targeted therapy. [1] Her research has expanded to include the use of CRISPR-Cas9 mediated therapeutic editing of genes involved in disease causing such as PARP1, Rpe65 and Mct8. [4] [5]

Additionally, Lee has published clinical guidelines for the management of acromegaly, adrenal incidenteloma, and atrial fibrillation. [6] [7]

Awards and honors

Lee was awarded the 2011 Jane C. Wright M.D. Young Investigator Award from the American Society of Clinical Oncology and the 2012 New York Ovarian Cancer Research Award from the Foundation for Women's Cancers. [2] [3]

Related Research Articles

<span class="mw-page-title-main">Roxana Moslehi</span> Genetic epidemiologist

Roxana Moslehi is an Iranian-born genetic epidemiologist.

<i>Did We Really Love?</i> 1999 South Korean drama series

Did We Really Love? is a South Korean drama series broadcast by MBC in 1999. Starring Bae Yong-joon, the series portrays the struggles between love, happiness, and the pursuit of material success.

<span class="mw-page-title-main">Cediranib</span> Chemical compound

Cediranib is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.

<span class="mw-page-title-main">South Korea women's national volleyball team</span>

The South Korea women's national volleyball team represents South Korea in international volleyball competitions and friendly matches. It was one of the leading squads in the world in the 1970s, 1990s and 2010s, having won the bronze medal at the 1976 Summer Olympics in Montreal, Quebec, Canada, and placing fourth at the 1972 Summer Olympics in Munich, Germany, the 2012 Summer Olympics in London, Great Britain and the 2020 Summer Olympics in Tokyo, Japan.

<span class="mw-page-title-main">South Korea men's national volleyball team</span> Mens national volleyball team representing South Korea

The South Korea men's national volleyball team represents South Korea in international volleyball competitions and friendly matches, governed by Korea Volleyball Association. The Republic of Korea (ROK) has competed in the Olympic Games eight times, but has not featured since the 2000 Olympic Games in Sydney, Australia. The national team's best performance at the Olympic Games was 5th place at the 1984 Games in Los Angeles, California, United States. The national team at the FIVB World Championship competed nine times, with their best result at 4th place in 1978. On continental level, The national team won three gold medals at the Asian Games in 1978, 2002 and 2006. And at the Asian Championship, the national team won four gold medals, two of these was at home in 1989 Seoul and 2001 Changwon and the other two are in 1993 and 2003. The national team now ranks 30th in the FIVB World Rankings and their current head coach is Im Do-heon.

<i>Giant</i> (TV series) 2010 South Korean television series

Giant is a 2010 South Korean television series starring Lee Beom-soo, Park Jin-hee, Joo Sang-wook, Hwang Jung-eum, Park Sang-min, and Jeong Bo-seok. It aired on SBS from May 10 to December 7, 2010 every Mondays and Tuesdays at 21:55 (KST) time slot for 60 episodes. Giant is a sprawling period drama about three siblings' quest for revenge during the economic boom of 1970-80s Korea. Tragically separated during childhood, the three reunite as adults and set out to avenge their parents' deaths, their fates playing out against a larger tide of power, money, politics, and the growth of a city.

The Korea National Ballet is a South Korean ballet company. It was founded in 1962 in Seoul as the National Ballet Company. It was one of the affiliates of the National Theater of Korea until 1999, when it separated to independently reestablish itself in the Seoul Arts Center in the following year.

iHQ Inc., doing business as SidusHQ is one of the leading talent management agencies in South Korea. It was founded in January 2001 by Teddy Hoon-tak Jung. The company is involved in talent management, and TV drama/music production.

<i>Quiz of God</i> South Korean television series

Quiz of God is a South Korean television series broadcast on cable channel OCN. It was the first medical/forensic crime investigation drama to air in Korea. The series follows genius but eccentric neurosurgeon and forensic doctor Han Jin-woo and his team as they solve suspicious deaths and unravel mysteries involving rare diseases.

The 2010 SBS Drama Awards is a ceremony honoring the best performances in television on the SBS network for the year 2010. It took place on December 31, 2010, at the SBS Open Hall in Deungchon-dong, Seoul, and was hosted by Lee Beom-soo, Park Jin-hee and Lee Soo-kyung.

Susan M. Domchek is an oncologist at the University of Pennsylvania, Executive Director of the Basser Center for BRCA, the Basser Professor in Oncology at the Perelman School of Medicine, and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at Penn Medicine. She has authored more than 250 articles in scholarly journals and serves on a number of editorial review boards. In 2018, Domchek was elected to the National Academy of Medicine.

<i>Watcher</i> (TV series) 2019 South Korean television series

Watcher is a 2019 South Korean television series starring Han Suk-kyu, Seo Kang-joon, and Kim Hyun-joo. It aired on OCN every Saturday and Sunday at 22:20 (KST) from July 6 to August 25, 2019.

<span class="mw-page-title-main">David Gius</span> American physician-scientist

David R. Gius is an American physician-scientist the Zell Family Scholar Professor, Women's Cancer Research Program director, and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family.

<i>Team Bulldog: Off-Duty Investigation</i> 2020 South Korean television series

Team Bulldog: Off-Duty Investigation (Korean: 번외수사) is a 2020 South Korean television series starring Cha Tae-hyun, Lee Sun-bin, Jung Sang-hoon, Yoon Kyung-ho and Ji Seung-hyun. It is the third series of OCN's "Dramatic Cinema" project which combines film and drama formats. It aired from May 23 to June 28, 2020.

<span class="mw-page-title-main">Christine Alewine</span> American oncologist and biologist

Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.

<span class="mw-page-title-main">Cho Yoon-kyoung</span>

Cho Yoon-Kyoung is an interdisciplinary researcher involved in basic science to translational research in microfluidics and nanomedicine. She is a group leader in the Center for Soft and Living Matter at the Institute for Basic Science (IBS) and a full professor in Biomedical Engineering at the Ulsan National Institute of Science and Technology (UNIST), Ulsan, Korea. Cho is a member of the National Academy of Engineering of Korea and a Fellow of the Royal Society of Chemistry.

<i>The King of Pigs</i> (TV series) 2022 South Korean web series

The King of Pigs is a South Korean web series starring Kim Dong-wook, Kim Sung-kyu, and Chae Jung-an. A live-action remake of Yeon Sang-ho's 2011 animated film of the same name, the series depicts a thriller drama of those who brought out memories of violence due to a mysterious serial murder that began with a message from a friend 20 years ago. It premiered on TVING on March 18, 2022.

<span class="mw-page-title-main">Eui-Cheol Shin</span> Korean immunologist

Eui-Cheol Shin is a Korean medical immunologist, academic, and author. He is a professor at the Graduate School of Medical Science and Engineering at the Korea Advanced Institute of Science and Technology (KAIST), and director of The Center for Viral Immunology at the Institute for Basic Science (IBS), a Korean government-funded research institute.

References

  1. 1 2 "Lasker Clinical Research Scholars". NIH Intramural Research Program. 2017-02-27. Retrieved 2020-10-10.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  2. 1 2 "Jung-Min Lee, M.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-10-10.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  3. 1 2 "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-10-10.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  4. ↑ Jo, Dong Hyun; Song, Dong Woo; Cho, Chang Sik; Kim, Un Gi; Lee, Kyu Jun; Lee, Kihwang; Park, Sung Wook; Kim, Daesik; Kim, Jin Hyoung; Kim, Jin-Soo; Kim, Seokjoong (October 2019). "CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis". Science Advances. 5 (10): eaax1210. Bibcode:2019SciA....5.1210J. doi:10.1126/sciadv.aax1210. ISSN   2375-2548. PMC   6821465 . PMID   31692906.
  5. ↑ Bae, Hee Sook; Jin, Yun-Kyeong; Ham, Sangwoo; Kim, Hee Kyoung; Shin, Hyejung; Cho, Gyu-Bon; Lee, Kyu Jun; Lee, Hohyeon; Kim, Kyeong-Min; Koo, Ok-Jae; Jang, Goo (July 2020). "CRISRP/Cas9-mediated knockout of Mct8 reveals a functional involvement of Mct8 in testis and sperm development in a rat". Scientific Reports. 10 (1): 11148. Bibcode:2020NatSR..1011148B. doi:10.1038/s41598-020-67594-2. ISSN   2045-2322. PMC   7341756 . PMID   32636400.
  6. ↑ Lee, Jung Min; Kim, Mee Kyoung; Ko, Seung Hyun; Koh, Jung Min; Kim, Bo Yeon; Kim, Sang Wan; Kim, Soo Kyung; Kim, Hae Jin; Ryu, Ohk Hyun; Park, Juri; Lim, Jung Soo (June 2016). "Clinical Guidelines for the Management of Adrenal Incidentaloma". Endocrinology and Metabolism (Seoul, Korea). 32 (2): 200–218. doi:10.3803/EnM.2017.32.2.200. ISSN   2093-596X. PMC   5503865 . PMID   28685511.
  7. ↑ Lee, Jung Min; Kim, Mee Kyoung; Ko, Seung Hyun; Koh, Jung Min; Kim, Bo Yeon; Kim, Sang Wan; Kim, Soo Kyung; Kim, Hae Jin; Ryu, Ohk Hyun; Park, Juri; Lim, Jung Soo (June 2017). "Clinical Guidelines for the Management of Adrenal Incidentaloma". Endocrinology and Metabolism (Seoul, Korea). 32 (2): 200–218. doi:10.3803/EnM.2017.32.2.200. ISSN   2093-596X. PMC   5503865 . PMID   28685511.
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.